BackHealthequity Overview

Healthequity Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$73.92M
14.07% YoY

As of Jul 31, 2026

Annual R&D Expenses (TTM)

$277.96M
10.7% YoY

Trailing 12 months ending Jul 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Healthequity (HQY) FAQ

Stockcircle tracks research & development for Healthequity (HQY), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Healthequity's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main HQY overview so you can move from this figure to the surrounding analysis quickly.